
Mansour Oveissi
Examiner (ID: 18658, Phone: (571)270-3127 , Office: P/2415 )
| Most Active Art Unit | 2415 |
| Art Unit(s) | 2616, 2464, 2415, 2416 |
| Total Applications | 1005 |
| Issued Applications | 795 |
| Pending Applications | 89 |
| Abandoned Applications | 156 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18034470
[patent_doc_number] => 20220378685
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-01
[patent_title] => FLUSHABLE WIPE AND METHOD OF FORMING THE SAME
[patent_app_type] => utility
[patent_app_number] => 17/885887
[patent_app_country] => US
[patent_app_date] => 2022-08-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16455
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -54
[patent_words_short_claim] => 83
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17885887
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/885887 | FLUSHABLE WIPE AND METHOD OF FORMING THE SAME | Aug 10, 2022 | Pending |
Array
(
[id] => 18075781
[patent_doc_number] => 20220401393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-22
[patent_title] => VALPROIC ACID FOR THE TREATMENT OR PREVENTION OF PATHOLOGICAL CONDITIONS ASSOCIATED WITH EXCESS FIBRIN DEPOSITION AND/OR THROMBUS FORMATION
[patent_app_type] => utility
[patent_app_number] => 17/816486
[patent_app_country] => US
[patent_app_date] => 2022-08-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 21420
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17816486
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/816486 | Valproic acid for the treatment or prevention of pathological conditions associated with excess fibrin deposition and/or thrombus formation | Jul 31, 2022 | Issued |
Array
(
[id] => 18143029
[patent_doc_number] => 20230016875
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS
[patent_app_type] => utility
[patent_app_number] => 17/815045
[patent_app_country] => US
[patent_app_date] => 2022-07-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10691
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 56
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17815045
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/815045 | HIGH CAPACITY DIKETOPIPERAZINE MICROPARTICLES AND METHODS | Jul 25, 2022 | Pending |
Array
(
[id] => 19290401
[patent_doc_number] => 12029740
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-07-09
[patent_title] => Amorphous nilotinib microparticles and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/866939
[patent_app_country] => US
[patent_app_date] => 2022-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 35884
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17866939
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/866939 | Amorphous nilotinib microparticles and uses thereof | Jul 17, 2022 | Issued |
Array
(
[id] => 18597629
[patent_doc_number] => 20230272426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-31
[patent_title] => METHOD FOR PREPARING PEI-LIPID NANOPARTICLES USED FOR DELIVERING A MRNA VACCINE AND TRANSFECTING STEM CELLS
[patent_app_type] => utility
[patent_app_number] => 17/862421
[patent_app_country] => US
[patent_app_date] => 2022-07-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3016
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 169
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17862421
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/862421 | Method for preparing PEI-lipid nanoparticles used for delivering a mRNA vaccine and transfecting stem cells | Jul 11, 2022 | Issued |
Array
(
[id] => 17944263
[patent_doc_number] => 20220331280
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-20
[patent_title] => Protection of Polyunsaturated Fatty Acids from Ruminal Degradation
[patent_app_type] => utility
[patent_app_number] => 17/810934
[patent_app_country] => US
[patent_app_date] => 2022-07-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6574
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17810934
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/810934 | Protection of Polyunsaturated Fatty Acids from Ruminal Degradation | Jul 5, 2022 | Issued |
Array
(
[id] => 18428692
[patent_doc_number] => 11673902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-06-13
[patent_title] => Isoindolinone and indazole compounds for the degradation of EGFR
[patent_app_type] => utility
[patent_app_number] => 17/843769
[patent_app_country] => US
[patent_app_date] => 2022-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 137637
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17843769
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/843769 | Isoindolinone and indazole compounds for the degradation of EGFR | Jun 16, 2022 | Issued |
Array
(
[id] => 17911232
[patent_doc_number] => 20220313627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Onychomycosis Treatment Compositions and Methods
[patent_app_type] => utility
[patent_app_number] => 17/840287
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840287 | Onychomycosis Treatment Compositions and Methods | Jun 13, 2022 | Pending |
Array
(
[id] => 17911232
[patent_doc_number] => 20220313627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-10-06
[patent_title] => Onychomycosis Treatment Compositions and Methods
[patent_app_type] => utility
[patent_app_number] => 17/840287
[patent_app_country] => US
[patent_app_date] => 2022-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14780
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 127
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17840287
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/840287 | Onychomycosis Treatment Compositions and Methods | Jun 13, 2022 | Pending |
Array
(
[id] => 19353114
[patent_doc_number] => 12053539
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-06
[patent_title] => Hair care compositions comprising hydroxylated triglyceride oligomers
[patent_app_type] => utility
[patent_app_number] => 17/838364
[patent_app_country] => US
[patent_app_date] => 2022-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 16975
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 171
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17838364
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/838364 | Hair care compositions comprising hydroxylated triglyceride oligomers | Jun 12, 2022 | Issued |
Array
(
[id] => 18019120
[patent_doc_number] => 20220370619
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => STABLE TRANSDERMAL AMPHETAMINE COMPOSITIONS AND METHODS OF MANUFACTURE
[patent_app_type] => utility
[patent_app_number] => 17/836883
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6062
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17836883
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/836883 | STABLE TRANSDERMAL AMPHETAMINE COMPOSITIONS AND METHODS OF MANUFACTURE | Jun 8, 2022 | Pending |
Array
(
[id] => 19378521
[patent_doc_number] => 20240268391
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-15
[patent_title] => MODIFIED CAST METAL OBJECT
[patent_app_type] => utility
[patent_app_number] => 18/567913
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4261
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567913
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567913 | MODIFIED CAST METAL OBJECT | Jun 8, 2022 | Pending |
Array
(
[id] => 19360987
[patent_doc_number] => 20240263021
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => ANTIVIRAL AND ANTIMICROBIAL BARRIER COATINGS
[patent_app_type] => utility
[patent_app_number] => 18/567181
[patent_app_country] => US
[patent_app_date] => 2022-06-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4540
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 11
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18567181
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/567181 | ANTIVIRAL AND ANTIMICROBIAL BARRIER COATINGS | Jun 8, 2022 | Pending |
Array
(
[id] => 19216109
[patent_doc_number] => 20240180813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER
[patent_app_type] => utility
[patent_app_number] => 18/552681
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552681 | AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER | May 30, 2022 | Pending |
Array
(
[id] => 19216109
[patent_doc_number] => 20240180813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-06
[patent_title] => AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER
[patent_app_type] => utility
[patent_app_number] => 18/552681
[patent_app_country] => US
[patent_app_date] => 2022-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16322
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18552681
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/552681 | AMINOSILOXANE ESTER COPOLYMER AND METHODS FOR THE PREPARATION AND USE OF THE COPOLYMER | May 30, 2022 | Pending |
Array
(
[id] => 19343471
[patent_doc_number] => 20240252434
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-01
[patent_title] => LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID
[patent_app_type] => utility
[patent_app_number] => 18/558335
[patent_app_country] => US
[patent_app_date] => 2022-05-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6807
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 360
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18558335
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/558335 | LIPID COMPOUND AND USE THEREOF IN DELIVERY OF NUCLEIC ACID | May 22, 2022 | Pending |
Array
(
[id] => 17836369
[patent_doc_number] => 20220273674
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-09-01
[patent_title] => EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/744932
[patent_app_country] => US
[patent_app_date] => 2022-05-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7315
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17744932
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/744932 | EXTENDED-RELEASE DRUG DELIVERY COMPOSITIONS | May 15, 2022 | Pending |
Array
(
[id] => 18056384
[patent_doc_number] => 20220387470
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-12-08
[patent_title] => METHODS OF MODULATING IMMUNE ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/743679
[patent_app_country] => US
[patent_app_date] => 2022-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 53495
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17743679
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/743679 | METHODS OF MODULATING IMMUNE ACTIVITY | May 12, 2022 | Pending |
Array
(
[id] => 19246633
[patent_doc_number] => 20240197617
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-20
[patent_title] => ANTI-AGING COSMETIC COMPOSITION BASED ON RESVERATROL AND MAGNOLIA
[patent_app_type] => utility
[patent_app_number] => 17/788895
[patent_app_country] => US
[patent_app_date] => 2022-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5651
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17788895
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/788895 | ANTI-AGING COSMETIC COMPOSITION BASED ON RESVERATROL AND MAGNOLIA | May 9, 2022 | Pending |
Array
(
[id] => 18020979
[patent_doc_number] => 20220372478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-24
[patent_title] => STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/737426
[patent_app_country] => US
[patent_app_date] => 2022-05-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25880
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -29
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17737426
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/737426 | STABILIZATION OF RNA FOR EXOGENOUS RNAi AGRICULTURAL APPLICATIONS AND FORMULATIONS | May 4, 2022 | Pending |